🌾 Farm Bill Hemp Cap Meets Spring Planting Reality

Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.

The hemp rewrite creates a simple problem with expensive consequences: the federal timeline lands in November, and the farm timeline lands in spring. The market is already reacting upstream, from acreage planning to buyer behavior.

Today’s edition is supported by 1440 Media and Fisher Investments. To sponsor Policy, Decoded and reach the executives, investors, and policymakers who read this briefing, reply to this email and we will send details.

🌾 The planting window
🚛 DOT holds the line
🥃 States narrow beverage lanes

Rules change late. Decisions happen early.

📌 What Happened: Congress tightened the federal hemp definition in a spending package, narrowing the lane that has carried hemp-derived THC into national commerce. Reporting describes a finished-product cap of 0.4 milligrams of total THC per package and a sharp turn against many converted cannabinoids that have fueled delta-8 and related markets. The change is already hitting the supply chain, with growers and processors hearing hesitation from buyers who do not want to lock acreage, biomass contracts, or extraction volumes under terms that may be illegal on arrival. The pressure reaches beyond intoxicating products because full spectrum CBD inputs often carry trace THC as a predictable byproduct of legitimate production. State regulators are tightening in parallel, steering low-dose beverages into age-gated channels while squeezing edibles and inhalables sold through convenience-style retail. The result is a narrower federal lane layered on top of a state-by-state map that keeps shifting.

💡 Why It Matters: The federal effective date creates a clean political talking point and a messy operational reality. Farmers do not get to plant on a congressional calendar, and processors do not get to finance expansion on a promise that the rules might soften later. When buyers hesitate, rural impacts land first: acreage pivots, lenders pull back, and processors carry idle capacity that cannot be wished away by a late-year fix. A strict package cap also raises stranded-inventory risk, because products built for today’s shelf can become unsellable before they clear wholesalers and retailers. For hemp beverages, survival depends on whether regulators preserve a disciplined, age-gated low-dose lane that fits the public-safety record and can be enforced in real channels. Converted cannabinoids and slapdash retail lanes sit closest to the enforcement blade because they drove the backlash that made this rewrite possible.

🚛 DOT Says Marijuana Testing Stays Put For Safety-Sensitive Jobs

The Transportation Department says President Trump’s rescheduling order does not change federal drug testing for safety-sensitive roles yet, and marijuana positives remain disqualifying under current DOT rules. DOT told laboratories, medical review officers, and program administrators to keep operating under existing requirements until the rescheduling process is complete. The agency also said its current guidance on medical marijuana, recreational marijuana, and CBD remains in effect. That keeps trucking, aviation, rail, transit, maritime, and pipeline workforces inside the same compliance box while employers manage retention, grievances, and incident response. The near-term consequence is clear: HR policies, collective bargaining posture, and safety programs stay anchored to today’s DOT framework. (Marijuana Moment)

🧾 Senate Bill Would Force DOJ To Stand Up A Federal Cannabis Commission

Sen. John Hickenlooper filed the PREPARE Act, a bill that would require the Attorney General to convene a “Commission on the Federal Regulation of Cannabis” within 30 days of enactment. The commission would study federal and state alcohol-style regulatory models and deliver recommendations to Congress within a year, covering product safety and labeling, banking and research barriers, and a federal revenue framework. The mandate also squarely addresses hemp coexistence, including recommendations aimed at preventing cross-pollination and managing the boundary between hemp and marijuana markets as rules tighten. The bill includes a partisan parity backstop to prevent a commission stacked by one party, plus seats for lived-experience and technical expertise, including a formerly incarcerated person and research specialists. The political consequence is a ready-made blueprint bill that can ride alongside rescheduling headlines, giving members a way to talk about federal standards without voting on full legalization yet. (Marijuana Moment)

🏛️ Wyden Calls Schedule III A Half-Step, Keeps Legalization Fight Alive

Sen. Ron Wyden framed President Trump’s rescheduling order as incomplete and argued the move leaves the industry without the stability that comes with federal legalization. He tied that critique to criminal justice, pointing to continued incarceration tied to cannabis while state markets expand. Wyden said he will keep pushing the Cannabis Administration and Opportunity Act as the vehicle to legalize federally and pair market access with record-clearing and equity goals. That stance clarifies the Democratic message heading into 2026: rescheduling may move taxes and research, while Congress still owns the durable market rules. The political consequence is a sharper contrast between administrative action and legislative demands as committees posture and interest groups pick their lanes. (Sierra Sun Times)

💳 Rescheduling Puts Credit Cards And Capital Back On The Table

Big MSOs are already building growth plans around Trump’s rescheduling push, with 280E relief framed as the first real cash-flow unlock. Ascend’s CEO said card acceptance could expand basket sizes once banks and networks loosen, while MariMed described the change as permission to move faster on new-state expansion. Executives also warned the upside comes with tighter expectations, including more traditional accounting and financial scrutiny as institutional money looks for clean controls. Curio Wellness said it built with an FDA-style lens and wants to lean into research and product development, including minor cannabinoids and condition-specific work. The business consequence is simple: companies that pair tax relief with disciplined finance, payments, and R&D infrastructure will separate from the pack when the next wave of capital comes shopping. (MJBizDaily)

🏷️ Curaleaf Virginia Deal Unravels After Rival Bid Raises The Price

Curaleaf terminated its agreement to acquire The Cannabist Company’s Virginia assets after a competing offer valued the package at $130 million and included assumption of a $30 million lease liability. Curaleaf said it completed diligence and concluded the price exceeded fair value, then walked away. The original deal remained inside a go-shop period that ran through December 22nd, and Curaleaf expects a $3.3 million break fee plus reimbursement of expenses up to $350,000. The Virginia package includes a cultivation facility and five dispensaries, plus the right to open one additional location. Virginia still commands premium bids, and disciplined buyers are drawing sharper lines on valuation even when scarcity stories sell well. (MJBizDaily)

🥃 New Jersey Moves Hemp THC Drinks Into A Liquor Store License Lane

New Jersey lawmakers are advancing a rewrite that tightens the hemp-derived cannabinoid market while creating a formal approval path for liquor stores to sell intoxicating hemp beverages. The Senate committee substitute directs the Cannabis Regulatory Commission to stand up a licensing and compliance process that runs alongside ABC retail and wholesale distribution licenses, with sales allowed under transition rules through November 13, 2026. The bill sets a low-dose beverage model starting March 13, 2026 with a 5 mg per serving cap, a 10 mg per container cap, and a required certificate of analysis from ISO 17025 accredited labs. It also adds a per-gallon excise tax and bans vending machine sales. The regulatory consequence is a narrow, age-gated, tested beverage lane with a shrinking footprint for gummies, vapes, and higher-dose products outside controlled channels. (Ganjapreneur)

🧩 Patchwork Hemp Rules Squeeze Multi-State Retailers

Retailers selling hemp-derived cannabinoid products across state lines are navigating THC limits, online sales bans, and channel restrictions that change at the border. Several states have routed low-dose beverages toward age-gated, licensed channels while tightening the rules that govern edibles and inhalables sold through convenience and smoke-shop lanes. That structure rewards brands with stable formulations, consistent testing, and packaging that can clear a shifting set of state definitions. The immediate business consequence lands in stop-sale exposure, rushed SKU resets, and wholesalers refusing inventory that may become noncompliant mid-quarter. Expansion starts to look like a compliance tax, and the risk concentrates in the products and channels that regulators are targeting first. (Heady NJ)

🍁 Hemp Crackdowns Threaten Canadian LPs’ U.S. Playbook

For years, hemp-derived THC gave Canadian cannabis companies a rare, federally legal way to build U.S. brands while the marijuana market stayed off-limits. StratCann argues that the window is narrowing as states tighten enforcement and Washington flirts with rewriting the Farm Bill lane that enabled delta-8 and high-dose hemp delta-9 products. Tilray, Organigram, Village Farms, Cronos, and others used hemp beverages and edibles as a bridge strategy, and that bridge now hinges on compliance discipline and channel legitimacy. Green Monké’s CEO frames the survivors as brands built like regulated consumer goods, with stable formulations, certified manufacturing, reliable testing, and packaging that can adapt quickly as standards rise. A crackdown that targets synthetics and slapdash channels can still leave room for disciplined, age-gated low-dose beverage models while forcing public Canadian issuers to reprice U.S. ambitions and capital plans on tighter legal footing. (StratCann)

🌲 Virginia Maps Adult Use Retail Launch For November 2026

Virginia Democrats are lining up a 2026 General Assembly push to finally open adult use cannabis sales, with a target launch date of November 1, 2026. The joint cannabis retail commission is floating a statewide cap of 350 retail licenses, an end to local opt-outs, and authority for localities to add up to a 3.5% sales tax. The plan puts the Cannabis Control Authority in charge of licensing, auditing, education, and a required tracking system, with applications envisioned by July 1st and licenses issued by September. Hemp and small cultivation voices are already warning that a tight timeline and new tracking requirements favor businesses with capital, compliance infrastructure, and ready supply. If lawmakers keep the schedule, local control and taxes become the choke points, and equity outcomes ride on whether the licensing pipeline stays fair while moving fast. (VPM)

🌾 Kentucky’s First Dispensary Sells Out And Pauses Operations

Kentucky’s first and only medical marijuana dispensary temporarily closed after selling out just days after opening in Beaver Dam. The Post opened December 13th and drew patients from across the state, with roughly 400 people in line before dawn on day one. The store sold about 1,000 eighth-ounce packages of flower, then ran out and now expects to reopen in mid-January when more in-state product becomes available. Kentucky’s in-state cultivation and processing requirement is shaping the rollout, with supply lagging demand nearly a year after legalization took effect. The immediate consequence is predictable: high prices, limited selection, and a political opening for critics who will frame scarcity as program failure rather than a startup constraint. (WDRB)

💰 Maryland Reports $26.8M In Cannabis Tax Revenue After Rate Hike

Maryland says it collected $26.8 million in adult use cannabis sales tax revenue from July through September 2025, the first full quarter after the rate increased from 9% to 12%. The state reports the Central Region led collections at about $10.8 million, followed by the Capital Region at about $6.5 million. Officials say the 3% rate increase generated about $6.7 million for the General Fund, with total General Fund receipts of about $11.7 million after statutory distributions. The Maryland Cannabis Administration received about $10.15 million, while counties, public health, and the business assistance fund each received about $500,000. The political consequence is predictable: Annapolis sees the revenue rise quickly, and local governments carrying zoning, inspection, and nuisance pressure keep pressing for a larger share. (NottinghamMD)

🌿 Mississippi Advocates Push Higher Potency Caps And A Right-To-Try Path For 2026

Mississippi medical cannabis advocates are teeing up a 2026 legislative agenda that would raise the flower potency cap from 30% to 40% and lift the current 60% limit on concentrates and infused products. They argue the concentrate limit pushes patients toward higher-volume consumption and undermines dose efficiency for people who rely on concentrates. The package also targets access friction, including a shift from annual recertification to every two years and broader practitioner discretion on qualifying conditions. Advocates are pressing a right-to-try option for patients whose conditions fall outside the statutory list. If lawmakers take this up, Mississippi’s program debate moves into clinical latitude and patient access, with potency and eligibility as the main fault lines. (Mississippi Free Press)

🕵️ Denver Grower Alleges Manager Emptied Warehouse In Multi-Day Cannabis Theft

A Denver cultivation company says its former facility manager used a key to strip a southside warehouse over several days, taking marijuana and equipment valued at at least $238,000. The suit says the alleged theft ran from September 19th through October 12th, and the owners discovered the scale after an alarm triggered on October 21st and they walked into a near-empty facility. The company claims security video shows cannabis being processed into bubble hash, followed by cameras disappearing and high-value items leaving the site. Police reportedly treated it as a civil and Marijuana Enforcement Division matter, and the former manager remains licensed by the state to handle cannabis. The operational consequence is a hard reminder that diversion risk can be internal, and controls have to cover keys, cameras, inventory movement, and off-hours access with real accountability. (BusinessDen)